In the front row, from left to right: Dr. Sonja Steppan (EASYGEN Principal Investigator, Fresenius SE), Prof. Dr. Michael Hudecek (Fraunhofer IZI), Theresa Kagerbauer (TQ Therapeutics), Dr. Agnes ...